acyclovir
- Product NDC
- 50090-0643
- 11-digit product format
- 500900643
- Labeler code
- 50090
- Product ID
- 50090-0643_fd470293-c61f-4e25-b8a9-ebe00201cfde
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA077309
- Marketing category
- ANDA
- Marketing start
- 2007-06-09
- Marketing end
- 0000-00-00
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-0643-0 | 50090064300 | 90 TABLET in 1 BOTTLE (50090-0643-0) | 90 tablet | 2014-11-28 | 0000-00-00 | No | No | Current |
| 50090-0643-1 | 50090064301 | 21 TABLET in 1 BOTTLE (50090-0643-1) | 21 tablet | 2019-10-23 | 0000-00-00 | No | No | Current |